These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27670099)

  • 1. Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors.
    Pissarnitski DA; Zhao Z; Cole D; Wu WL; Domalski M; Clader JW; Scapin G; Voigt J; Soriano A; Kelly T; Powles MA; Yao Z; Burnett DA
    Bioorg Med Chem; 2016 Nov; 24(21):5534-5545. PubMed ID: 27670099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: synthesis, SAR and biological evaluation.
    Kim HJ; Kwak WY; Min JP; Sung SY; Kim HD; Kim MK; Kim HS; Park KJ; Son MH; Kim SH; Lee BJ
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5545-9. PubMed ID: 22850208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
    Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
    ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
    Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
    Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study.
    Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G
    Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
    Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
    Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H
    Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
    Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and biological activity of substituted xanthines as DPP-Ⅳ inhibitors].
    Li YP; Yi H; Jiang XB; Li ZR
    Yao Xue Xue Bao; 2016 Jun; 51(6):947-53. PubMed ID: 29879349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
    Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
    J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Singh D; Gupta M
    Chem Biol Drug Des; 2013 Feb; 81(2):257-64. PubMed ID: 23039850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of dipeptidyl peptidase 4 inhibitory peptides from Largemouth bass (Micropterus salmoides) by a comprehensive approach.
    Wang K; Yang X; Lou W; Zhang X
    Bioorg Chem; 2020 Dec; 105():104432. PubMed ID: 33157343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
    Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
    Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
    Rusinov VL; Sapozhnikova IM; Bliznik AM; Chupakhin ON; Charushin VN; Spasov AA; Vassiliev PM; Kuznetsova VA; Rashchenko AI; Babkov DA
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28393419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice.
    Ran Y; Pei H; Xie C; Ma L; Wu Y; Lei K; Shao M; Tang M; Xiang M; Peng A; Wei Y; Chen L
    Mol Divers; 2015 May; 19(2):333-46. PubMed ID: 25672287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
    Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
    Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site.
    Wang W; Devasthale P; Wang A; Harrity T; Egan D; Morgan N; Cap M; Fura A; Klei HE; Kish K; Weigelt C; Sun L; Levesque P; Li YX; Zahler R; Kirby MS; Hamann LG
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6646-51. PubMed ID: 21996520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.
    Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
    Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.